Factors Influencing Readmission Rates of Acute Traumatic Subdural Hematoma in the Elderly

Tarik Wasfie, MD

Status: Completed

Conditions: Traumatic Subdural Hematoma

Treatments: Other: Follow-up Care

Study type: Observational

Funder types: Industry

Identifiers

NCT03878043

GRMC 160013

Details and patient eligibility

About

Acute traumatic subdural hematomas (TSDH) readmission rate is high (27.8%) with an increase in morbidity and cost for the elderly. This study identifies risk factors affecting readmission rates for these patients and presents strategies to reduce it.

Full description

A retrospective analysis was conducted on patients with traumatic brain injuries (ICD-9-CM codes 800.20 - 801.86, 852.00 - 853.05) admitted between 2014 and 2016 at Genesys Regional Medical Center through the trauma service. From this group, the investigators selected patients admitted with traumatic SDH, and those patients were followed over the following 6 months as regards to readmission status. Patients who were readmitted versus patients who were not readmitted were compared. The risk of readmission within 6 months of discharge for SDH was analyzed adjusting for age, prior anticoagulation use, Injury Severity Score (ISS), Glasgow Coma Scale (GCS), gender, time to readmission and co-morbid conditions which included diabetes mellitus, cardiovascular disease, renal disease, chronic obstructive pulmonary disease, and osteoporotic/orthopedic fractures using Cox Proportional Hazards Regression analysis.

Enrollment: 167 patients

Sex: All

Ages: 18 to 105 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients diagnosed with Traumatic Subdural Hematoma during time of study

Exclusion criteria

• Patients who expired.

Trial design

167 participants in 2 patient groups

Patients without Readmissions

Description:

Patients with TSDH who were not readmitted within a 6-month time period following their initial visit.

Patients with Readmissions

Description:

Patients with TSDH who were readmitted within a 6-month time period following their initial visit.

Treatment:

Other: Follow-up Care